Supratentorial Glioblastoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06186 | Ipilimumab | 1 | Completed | 1 |
DB00358 | Mefloquine | 1 | Active Not Recruiting | 1 |
DB01043 | Memantine | 1 | Active Not Recruiting | 1 |
DB00331 | Metformin | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Completed | 1 |
DB00853 | Temozolomide | 1 | Active Not Recruiting | 1 |
DB00853 | Temozolomide | 1 | Completed | 1 |
DB11919 | 6-O-benzylguanine | 2 | Recruiting | 1 |
DB00262 | Carmustine | 2 | Recruiting | 1 |
DB00099 | Filgrastim | 2 | Recruiting | 1 |
DB09502 | Fludeoxyglucose (18F) | 2 | Active Not Recruiting | 1 |
DB17217 | Lerapolturev | 2 | Active Not Recruiting | 1 |
DB09330 | Osimertinib | 2 | Active Not Recruiting | 1 |
DB17093 | P140K methylguanine-DNA-methyltransferase mutant CD34+ cells | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Suspended | 1 |
DB00853 | Temozolomide | 2 | Recruiting | 1 |
DB00853 | Temozolomide | 2 | Suspended | 1 |
DB01099 | Flucytosine | 2 / 3 | Withdrawn | 1 |
DB00853 | Temozolomide | 2 / 3 | Withdrawn | 1 |
DB15331 | Vocimagene amiretrorepvec | 2 / 3 | Withdrawn | 1 |
DB00112 | Bevacizumab | 3 | Completed | 1 |
DB00853 | Temozolomide | 3 | Completed | 1 |